Increase in brain tumors is not attributed to mobile phone use
the ONA take:
New research from the University of Auckland found that risk of brain cancer is not increased by mobile phone use. Concerns have been raised about whether use of mobile phones can increase the incidence of brain cancers.
Previous studies from around the world reported findings that showed no risk or a slightly increased risk, with some studies suggesting a substantial risk.
The New Zealand team examined the frequency of brain cancers in total and in subtypes highlighted in other studies, using data from the New Zealand cancer registry.
These investigators found no general increase. They did see, however, was a decrease of approximately 1% per year in people 10 to 69 years. Based on their findings, they report previous findings of large increases in risk are likely to be incorrect.
However, they concede that a study of this type cannot exclude a small risk, or one limited to certain subtypes of cancers, or a risk arising after more than 15 years of phone use.
The research team cannot explain the decrease in brain cancers in New Zealand. An increase in some types of brain cancer among people 70 years and older—in New Zealand and other countries—may be related to improved diagnosis.
Brain cancer is not increased by mobile phone use.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|